Halloran PF - Search Results

1

The therapeutic challenge of late antibody-mediated kidney allograft rejection.

Böhmig GA, Eskandary F, Doberer K, Halloran PF. Böhmig GA, et al. Among authors: halloran pf. Transpl Int. 2019 Aug;32(8):775-788. doi: 10.1111/tri.13436. Epub 2019 May 7. Transpl Int. 2019. PMID: 30955215 Free PMC article. Review.

2

The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.

Halloran PF, Schlaut J, Solez K, Srinivasa NS. Halloran PF, et al. Transplantation. 1992 Mar;53(3):550-5. Transplantation. 1992. PMID: 1549846

3

Major histocompatibility complex antigens and murine islet allograft survival.

Kneteman NM, Halloran PF, Sanden WD, Wang T, Seelis RE. Kneteman NM, et al. Among authors: halloran pf. Transplantation. 1991 Jan;51(1):247-51. doi: 10.1097/00007890-199101000-00041. Transplantation. 1991. PMID: 1987695

4

The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection.

Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. Halloran PF, et al. Transplantation. 1990 Jan;49(1):85-91. doi: 10.1097/00007890-199001000-00019. Transplantation. 1990. PMID: 2301035

5

The molecular immunology of acute rejection: an overview.

Halloran PF, Broski AP, Batiuk TD, Madrenas J. Halloran PF, et al. Transpl Immunol. 1993;1(1):3-27. doi: 10.1016/0966-3274(93)90055-d. Transpl Immunol. 1993. PMID: 8081760 Review. No abstract available.

6

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.

Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, et al. Solez K, et al. Among authors: halloran pf. Kidney Int. 1993 Aug;44(2):411-22. doi: 10.1038/ki.1993.259. Kidney Int. 1993. PMID: 8377384 Free article.

7

The Banff schema for allograft pathology: the end of the beginning.

Halloran P. Halloran P. Transplant Proc. 1996 Feb;28(1):500-1. Transplant Proc. 1996. PMID: 8644328 No abstract available.

8

Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema.

Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Trpkov K, et al. Among authors: halloran pf. Transplantation. 1996 Jun 15;61(11):1586-92. doi: 10.1097/00007890-199606150-00007. Transplantation. 1996. PMID: 8669102

9

In vivo immunosuppressive mechanisms.

Halloran PF, Miller LW. Halloran PF, et al. J Heart Lung Transplant. 1996 Oct;15(10):959-71. J Heart Lung Transplant. 1996. PMID: 8913912 Review. No abstract available.

10

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Halloran P, et al. Transplantation. 1997 Jan 15;63(1):39-47. doi: 10.1097/00007890-199701150-00008. Transplantation. 1997. PMID: 9000658 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters